Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
ROCHE PALO ALTO LLC et al v. LUPIN PHARMACEUTICALS, INC. et al
Case Number:
2:10-cv-03561
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
August 13, 2013
Gilead, Roche Settle Ranexa Patent Suit Against Lupin
Gilead Sciences Inc. and Roche Palo Alto LLC have abandoned a patent infringement suit trying to block Lupin Ltd. from offering a copycat version of chronic chest pain treatment Ranexa, telling a New Jersey federal judge Friday that they'd resolved their dispute.
-
March 08, 2013
Lupin Can't Escape Gilead's Ranexa Patent Suit
A New Jersey federal judge on Thursday refused generic-drug maker Lupin Ltd.'s request to boot a patent infringement suit brought by Gilead Sciences Inc. over its chest pain drug Ranexa, rejecting Lupin's contention that the claims raised were invalid.